ASCENDIS PHARMA A/S 2.25 04/01/2028 SDBCV

ASCENDIS PHARMA A/S 2.25 04/01/2028 SDBCV is a security (CUSIP 04351PAD3) tracked across SEC portfolio filings. 34 institutional managers reported $734.2M on Form 13F as of 2026-03-31; 3 registered fund positions totaling $4.9M via N-PORT as of 2026-04-30.

Summary

Top institutional holders (Form 13F)

Showing 15 of 34 managers by value.

ManagerLocationValueShares
Linden Advisors LPNew York, NY$205.5M139,570,000
WOLVERINE ASSET MANAGEMENT LLCCHICAGO, IL$116.3M79,235,000
DeepCurrents Investment Group LLCNEW YORK, NY$73.3M49,894,000
Point72 Asset Management, L.P.Stamford, CT$70.5M47,794,000
FRANKLIN RESOURCES INCSan Mateo, CA$69.6M47,320,000
CAPSTONE INVESTMENT ADVISORS, LLCNEW YORK, NY$51.0M34,659,000
Boussard & Gavaudan Investment Management LLPLondon, X0$18.8M12,900
STATE STREET CORPBOSTON, MA$18.4M12,446,000
PFM Health Sciences, LPSan Francisco, CA$16.9M11,505,000
SSI INVESTMENT MANAGEMENT LLCLos Angeles, CA$15.9M10,834,000
BlackRock, Inc.New York, NY$13.5M9,175,000
Nicholas Investment Partners, LPRANCHO SANTA FE, CA$8.9M6,035,000
DAFNA Capital Management LLCLOS ANGELES, CA$5.9M4,000,000
BNP PARIBAS ARBITRAGE, SNCPARIS, I0$5.3M3,642,000
Jefferies Financial Group Inc.NEW YORK, NY$5.2M3,511,000

Top fund holders (N-PORT)

FundRegistrantValue% of fund
Putnam Convertible Securities FundPutnam Convertible Securities Fund$4.1M72.74%
Virtus Global Allocation FundVirtus Strategy Trust$528K36.01%
Putnam Diversified Income TrustPutnam Diversified Income Trust$266K2.89%

More